It is worth considering that the sample size and proportion of ICC in this study were relatively low, which may be a potential reason for the significantly lower prevalence of IDH1 alterations in Chinese BTC patients than in Western BTC patients. This evidence concerns the gene IDH1 and intrahepatic cholangiocarcinoma.